Stay updated on Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The Czech location/region naming for “Olomouc Region” was updated from a different (Czech-language) form to a new display form, while keeping the same place and postal code. The page also reflects an update to the site build/revision version string.
    Difference
    0.1%
    Check dated 2026-04-24T05:56:26.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision updated from v3.5.0 to v3.5.2.
    Difference
    0.0%
    Check dated 2026-04-17T02:32:52.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    37 days ago
    Change Detected
    Summary
    The site revision was updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-19T04:17:58.000Z thumbnail image
  5. Check
    44 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.4.3, replacing Revision: v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-11T23:31:22.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added to the page; the funding-status notice about a lapse in government funding and the previous Revision: v3.4.1 were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-02-11T14:20:42.000Z thumbnail image
  7. Check
    80 days ago
    Change Detected
    Summary
    - The page now displays a site-wide notice about government funding status and NIH Clinical Center operations, and the revision has been updated from v3.4.0 to v3.4.1.
    Difference
    0.2%
    Check dated 2026-02-04T10:26:00.000Z thumbnail image

Stay in the know with updates to Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Cabozantinib vs Everolimus in Metastatic Renal Cell Carcinoma Clinical Trial page.